A forum of leading hepatologists, endocrinologists and clinical development experts stewarding advances in science, clinical research and therapeutics for nonalcoholic fatty liver disease and steatohepatitis
UPCOMING EVENTS
4th NASH Roundtable Virtual Forum
November 18, 2021 at 11:30 AM PST / 2:30 PM EST.
RESOURCES
Fact Sheet: NASH Roundtable, leading clinical development experts addressing challenges in NASH drug development
View Fact Sheet »MEMBER CO-AUTHORED PUBLICATIONS
September, 2021
Randomized clinical trial: Semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging. Read More »
September, 2021
Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease. Read More »
September, 2021
A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Non-alcoholic Fatty Liver Disease. Read More »
September, 2021
Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review. Read More »